Onco360
Hospitals & Physicians Clinics · Kentucky, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
13410 Eastpoint Centre Dr Ste 101, Louis...Phone Number
(877) 662-6633Website
www.onco360.comRevenue
$266.7 MillionIndustry
ZI Rank: 4
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
11
10
8
9
4
About Onco360
Founded in 2003, Onco360 provides health care services specializing in oncology pharmaceutical and care management services to physicians and patients. Onco360 is located in Kentucky.Explore more
Onco360 Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Onco360 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Onco360
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Onco360 had a recent Job posting/layoffs
Check if Onco360 has recently received funding, and reach out quickly before it becomes old news!
Onco360, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Onco360 is spiking on competitors!
Earning: See what the market has to say on Onco360 recently announced quarterly report
Product Launch: Get notified when Onco360 launches new products
Funding: Get notified immidiatlly once Onco360 has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Onco360
Find 2 more new buyers
Compare Similar Companies to Onco360
Compare insights from companies similar to Onco360, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Onco360 is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Onco360 is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Onco360.
Onco360 Tech Stack
A closer look at the technologies used by Onco360
Most Recent Scoops
Event
Product Marketing, Events, Sales, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations, Patient Experience
Event
Product Marketing, Events, Sales, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations, Patient Experience
Hiring Plans
Onco360 has more open roles in Marketing than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Onco360 has more open roles in Finance than it has had at any time in the past 12 months with an increased focus that include Billing, Commercial Insurances, Commercial Insurances, and Billing, and experience with Collections.
Hiring Plans
Hiring Plans
Hiring Plans
Onco360 News & Media
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for IMKELDI® (imatinib) Oral Solution
LOUISVILLE, KY, June 02, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Shorla Oncology for IMKELDI® (imatinib) Oral Solution, indicated for the treatment of newly diagnosed Philadelphia-positive (Ph+ CML) chronic myeloid leukemia, Ph+ CML in blast crisis, accelerated phase or chronic phase after interferon-alpha therapy, adult and pediatric patients with Ph+ ALL, myelodysplastic/myeloproliferative disease (MDS/MOnco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)
LOUISVILLE, Ky., March 26, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Corcept Therapeutics for LIFYORLI™ (relacorilant), which is indicated in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens, at least one of which included bevacizumab.Onco360® Has Been Selected as the National Pharmacy Partner for UNLOXCYT™ (cosibelimab-ipdl)
LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT™ (cosibelimab-ipdl). UNLOXCYT is the first and only PD-L1 immune checkpoint inhibitor approved for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.1Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio
LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy partner for TAVALISSE® (fostamatinib disodium hexahydrate), GAVRETO® (pralsetinib), and REZLIDHIA® (olutasidenib).
Read more news
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding Onco360
Sign Up For FreeTo access detailed company insights
Founded in 2003, Onco360 provides health care services specializing in oncology pharmaceutical and care management services to physicians and patients. Onco360 is located in Kentucky.... Read More
